Tracy has over 25 years of experience in global drug development, including oversight of all phases of clinical trials and drug development across multiple therapeutic areas. Most recently at Lyndra Therapeutics, Tracy was Vice President of Clinical Development, overseeing clinical operations, data management and medical writing across the company’s pipeline programs. Prior to Lyndra, Tracy was Head of Clinical Operations at Crozet BioPharma LLC, a biopharmaceutical company working on vaccines against Marburg and Nipah viruses with funding from BARDA and CEPI. Prior to Crozet, Tracy was working with the ID Division of NewLink Genetics Systems, responsible for the oversight of clinical operations and contract activities supporting the development of the rVSV-ZEBOV Ebola vaccine, in partnership with Merck & Co. Tracy has worked on numerous vaccine programs, including Japanese encephalitis, West Nile, Helicobacter pylori, Clostridium difficile and the ACAM2000® smallpox vaccine while at Acambis. She has significant experience in clinical contract and budget management, program feasibility, identification and management of strategic partners, as well as internal/external team management. Tracy did her undergraduate work at Rollins College and has a Master’s Degree in Public Health from Boston University with a focus in Epidemiology.